Found: 117
Select item for more details and to access through your institution.
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 10, p. 6782, doi. 10.1007/s00415-024-12638-0
- By:
- Publication type:
- Article
Correction to: Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Brain reserve and timing of clinical onset in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 10, p. 1290, doi. 10.1177/13524585241272046
- By:
- Publication type:
- Article
Disability patterns in multiple sclerosis: A meta-analysis on RAW and PIRA in the real-world context.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 10, p. 1309, doi. 10.1177/13524585241266180
- By:
- Publication type:
- Article
The Contribution of Illness Beliefs, Coping Strategies, and Social Support to Perceived Physical Health and Fatigue in Multiple Sclerosis.
- Published in:
- Journal of Clinical Psychology in Medical Settings, 2021, v. 28, n. 1, p. 149, doi. 10.1007/s10880-019-09692-6
- By:
- Publication type:
- Article
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0180651
- By:
- Publication type:
- Article
Non-traumatic acute myelopathies: Clinical and imaging features in a real world emergency setting.
- Published in:
- Neuroradiology Journal, 2022, v. 35, n. 6, p. 727, doi. 10.1177/19714009221096823
- By:
- Publication type:
- Article
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy.
- Published in:
- Neuroepidemiology, 2017, v. 48, n. 3/4, p. 171, doi. 10.1159/000479515
- By:
- Publication type:
- Article
Modulation of P2X7 receptor during inflammation in Multiple sclerosis.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01529
- By:
- Publication type:
- Article
Mapping the Progressive Treatment-Related Reduction of Active MRI Lesions in Multiple Sclerosis.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.585296
- By:
- Publication type:
- Article
Dynamics of pseudo‐atrophy in RRMS reveals predominant gray matter compartmentalization.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 3, p. 623, doi. 10.1002/acn3.51302
- By:
- Publication type:
- Article
Visual pathway neurodegeneration winged by mitochondrial dysfunction.
- Published in:
- Annals of Clinical & Translational Neurology, 2015, v. 2, n. 2, p. 140, doi. 10.1002/acn3.157
- By:
- Publication type:
- Article
CD28 Autonomous Signaling Up-Regulates C-Myc Expression and Promotes Glycolysis Enabling Inflammatory T Cell Responses in Multiple Sclerosis.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 6, p. 575, doi. 10.3390/cells8060575
- By:
- Publication type:
- Article
Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 6, p. 533, doi. 10.3390/cells8060533
- By:
- Publication type:
- Article
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 856, doi. 10.1177/13524585231167515
- By:
- Publication type:
- Article
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 14, p. 2243, doi. 10.1177/13524585221114007
- By:
- Publication type:
- Article
Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 years.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2137, doi. 10.1177/13524585221079598
- By:
- Publication type:
- Article
Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 885, doi. 10.1177/13524585211045545
- By:
- Publication type:
- Article
Age-related adverse events of disease-modifying treatments for multiple sclerosis: A meta-regression.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 9, p. 1391, doi. 10.1177/1352458520964778
- By:
- Publication type:
- Article
The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 968, doi. 10.1177/1352458520943777
- By:
- Publication type:
- Article
Single-subject structural cortical networks in clinically isolated syndrome.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 11, p. 1392, doi. 10.1177/1352458519865739
- By:
- Publication type:
- Article
Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 3, p. 352, doi. 10.1177/1352458517751647
- By:
- Publication type:
- Article
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 8, p. 1039, doi. 10.1177/1352458517711774
- By:
- Publication type:
- Article
Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 2, p. 212, doi. 10.1177/1352458515581436
- By:
- Publication type:
- Article
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1713, doi. 10.1177/1352458515570768
- By:
- Publication type:
- Article
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 9, p. 1265, doi. 10.1177/1352458514521311
- By:
- Publication type:
- Article
Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 1, p. 64, doi. 10.1177/1352458511417481
- By:
- Publication type:
- Article
Impaired cortical deactivation during hand movement in the relapsing phase of multiple sclerosis: a cross-sectional and longitudinal fMRI study.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 10, p. 1177, doi. 10.1177/1352458511411757
- By:
- Publication type:
- Article
Stopping Disease-Modifying Treatments in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Real-World Studies.
- Published in:
- CNS Drugs, 2023, v. 37, n. 10, p. 915, doi. 10.1007/s40263-023-01038-z
- By:
- Publication type:
- Article
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.898741
- By:
- Publication type:
- Article
Humoral and Cellular Response to Spike of Delta SARS-CoV-2 Variant in Vaccinated Patients With Multiple Sclerosis.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.881988
- By:
- Publication type:
- Article
Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy.
- Published in:
- PLoS ONE, 2022, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0264123
- By:
- Publication type:
- Article
Longitudinal Assessment of Multiple Sclerosis with the Brain-Age Paradigm.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Deep gray matter volume loss drives disability worsening in multiple sclerosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis.
- Published in:
- Annals of Neurology, 2013, v. 73, n. 5, p. 626, doi. 10.1002/ana.23875
- By:
- Publication type:
- Article
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis.
- Published in:
- Clinical Science, 2015, v. 129, n. 4, p. 291, doi. 10.1042/CS20140608
- By:
- Publication type:
- Article
Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis.
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 4, p. 1, doi. 10.1371/journal.ppat.1003220
- By:
- Publication type:
- Article
Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl<sup>®</sup>.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
A Comprehensive Review on Copemyl.
- Published in:
- Neurology & Therapy, 2017, v. 6, n. 2, p. 161, doi. 10.1007/s40120-017-0079-3
- By:
- Publication type:
- Article
Noninvasive Assessment of Mitoxantrone Cardiotoxicity in Relapsing Remitting Multiple Sclerosis.
- Published in:
- 1995
- By:
- Publication type:
- Other
Predictors of long–term clinical response to interferon beta therapy in relapsing multiple sclerosis.
- Published in:
- Journal of Neurology, 2006, v. 253, n. 3, p. 287, doi. 10.1007/s00415-005-0979-5
- By:
- Publication type:
- Article
Monthly corticosteroids decrease neutralizing antibodies to IFNβ1b: a randomized trial in multiple sclerosis.
- Published in:
- Journal of Neurology, 2002, v. 249, n. 1, p. 50, doi. 10.1007/PL00007847
- By:
- Publication type:
- Article
The use of magnetic resonance imaging in multiple sclerosis treatment trials: power calculations for annual lesion load measurement.
- Published in:
- Journal of Neurology, 2000, v. 247, n. 1, p. 34, doi. 10.1007/s004150050007
- By:
- Publication type:
- Article
Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: relationship to clinical parameters.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Anti-RBD Antibody Levels and IFN-γ-Specific T Cell Response Are Associated with a More Rapid Swab Reversion in Patients with Multiple Sclerosis after the Booster Dose of COVID-19 Vaccination.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 926, doi. 10.3390/vaccines12080926
- By:
- Publication type:
- Article
Proinflammatory mucosal)associated invariant CD8+ T cells react to gut flora yeasts and infiltrate multiple sclerosis brain.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.890298
- By:
- Publication type:
- Article
Ozone‐induced encephalopathy: A novel iatrogenic entity.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 8, p. 2471, doi. 10.1111/ene.14793
- By:
- Publication type:
- Article
Scoring the 10‐year risk of ambulatory disability in multiple sclerosis: the RoAD score.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 8, p. 2533, doi. 10.1111/ene.14845
- By:
- Publication type:
- Article
Efficacy of prolonged-release fampridine versus placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCE.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2022, p. 1, doi. 10.1177/17562864221090398
- By:
- Publication type:
- Article